BRIEF-Jazz Pharma submits Vyxeo Marketing Authorization Application to European Medicines Agency
November 03, 2017 at 08:41 AM EDT
* Jazz Pharmaceuticals submits Vyxeos™ Marketing Authorization Application to European Medicines Agency for treatment of certain types of high-risk acute myeloid leukemia Source text for Eikon: Further company coverage:
